Related Experiment Video
Updated: Jul 17, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
PIK3CA mutations in cutaneous squamous cell carcinoma
Yudo Kusaba1, Ikko Kajihara1, Ryoko Sakamoto1
1Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
This study found the prevalence of PIK3CA hotspot mutations in cutaneous squamous cell carcinoma (cSCC). PIK3CA mutations were detected in 5.0% of cSCC cases, with no significant correlation to clinical characteristics.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Oncogenic PIK3CA mutations activate PI3K-AKT signaling, promoting cancer growth.
- PIK3CA mutations are key biomarkers for targeted therapies, particularly PI3K inhibitors.
- Hotspot mutations in exons 9 and 20 account for most PIK3CA alterations in human cancers.
Purpose of the Study:
- To determine the prevalence of three PIK3CA hotspot mutations (E542K, E545K, H1047R) in cutaneous squamous cell carcinoma (cSCC).
- To evaluate the correlation between PIK3CA mutations and clinical characteristics in cSCC patients.
Main Methods:
- Utilized digital droplet PCR (ddPCR) to analyze PIK3CA hotspot mutations in 143 cSCC cases.
- Investigated the frequency of E542K, E545K, and H1047R mutations.
Main Results:
- The overall frequency of PIK3CA hotspot mutations in cSCC was 5.0% (7/143).
- Individual mutation frequencies were: E542K (1.4%), E545K (2.8%), and H1047R (0.7%).
- No significant correlation was observed between PIK3CA mutations and clinical characteristics.
Conclusions:
- This study establishes the prevalence of PIK3CA hotspot mutations in cSCC.
- While PIK3CA mutations did not correlate with clinical features in this cohort, targeted therapies like PI3K inhibitors may hold potential for mutation-positive cSCC.
- Further research and clinical trials are warranted to explore therapeutic strategies for PIK3CA-mutated cSCC.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Ras Gene
Ras is a...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Induced Pluripotent Stem Cells
Somatic...

